San Diego, CA, United States of America

John J Grigsby, Jr

USPTO Granted Patents = 25 

Average Co-Inventor Count = 4.8

ph-index = 11

Forward Citations = 257(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
25 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of John J. Grigsby, Jr.: A Pioneer in Pharmaceutical Patents

Introduction: John J. Grigsby, Jr. is a renowned inventor based in San Diego, CA, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 16 patents, Grigsby has been at the forefront of developing innovative solutions that enhance drug manufacturing processes, particularly in the realm of anesthetics.

Latest Patents: Among his latest inventions, Grigsby has focused on the manufacturing of bupivacaine multivesicular liposomes (MVLs). His patents detail embodiments that describe batches of bupivacaine MVLs prepared through a sophisticated commercial manufacturing process utilizing independently operating dual tangential flow filtration modules. These innovations represent a new and improved large-scale manufacturing process for bupivacaine MVLs, which result in high yields, improved stabilities, and desired particle size distributions. These advancements are poised to positively impact patient care by enhancing the delivery mechanisms of anesthetics.

Career Highlights: Grigsby is currently affiliated with Pacira Pharmaceuticals, Inc., a company that emphasizes innovation in drug formulation and delivery. His work has not only propelled the company forward but has also solidified his position as a key figure in pharmaceutical research and development.

Collaborations: Throughout his career, Grigsby has collaborated with notable professionals in the field, including Jeffrey S. Hall and David J. Turnbull. These partnerships have fostered a dynamic environment for brainstorming and executing groundbreaking projects, leading to the successful development of multiple patents that align with the industry's needs.

Conclusion: John J. Grigsby, Jr. exemplifies the dedication and ingenuity that define successful inventors in the pharmaceutical landscape. His contributions, especially in the manufacturing of bupivacaine multivesicular liposomes, showcase his commitment to improving drug delivery systems and patient outcomes. As he continues to innovate, the pharmaceutical industry eagerly anticipates the next chapter of his impactful career.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…